Sapio Sciences logoNews
March 19, 2025

Sapio Sciences: Seamless AI-Native Drug Discovery with NVIDIA BioNeMo

BALTIMORE--(BUSINESS WIRE)--Sapio Sciences, the science-aware™ lab informatics platform, today announced the integration of the NVIDIA BioNeMo platform into the Sapio…
Andy
Love0
AstraZenecaNews
March 19, 2025

BioPharmaDive: AstraZeneca adds ‘in vivo’ cell therapy capabilities with EsoBiotech deal

The British drugmaker is paying up to $1 billion to buy the Belgian startup, whose technology it sees as useful in…
Andy
Love0
Phlow logoNews
March 18, 2025

Phlow Corp. Achieves Key Milestone Toward Full Epinephrine Production — Made in America

Validation Completed for a Novel, Cost-Competitive Epinephrine Active Pharmaceutical Ingredient Process, Drug Master File Successfully Filed Richmond, Virginia, March 17,…
Andy
Love0
National Institutes of Health logoNews
March 17, 2025

The Economic Power of NIH Grants: Why Sustained Investment Matters

The National Institutes of Health (NIH) is vital in driving scientific discovery and economic growth across the United States. Recent…
Andy
Love0
MotivityAnnaNews
March 17, 2025

Motivity Secures $27M Investment to Scale ABA Tech with NIH Entrepreneur in Residence Support

HONOLULU, HI, Mar. 12, 2025 – Motivity, a leading provider of clinical SaaS solutions for Applied Behavior Analysis (ABA) providers…
Andy
Love0
ShuttleLogoNews
March 17, 2025

WBJ: This Md. biotech wants to get a cancer treatment to patients. It just tapped an industry outsider as co-CEO

By Sara Gilgore – Staff Reporter, Washington Business Journal -Mar 12, 2025 - Gaithersburg’s Shuttle Pharmaceuticals Holdings Inc. (NASDAQ: SHPH)…
Andy
Love0
CelSciNews
March 17, 2025

CEL-SCI’s Head and Neck Cancer Study Clears FDA Review, Eyes Commercialization Partners

VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE American: CVM) today announced it received comments from the U.S. Food and Drug Administration (FDA)…
Andy
Love0
GainNews
March 17, 2025

Gain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson’s Disease

BETHESDA, Md., March 14, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology…
Andy
Love0
GeneDX2News
March 14, 2025

GeneDx Enhances the Power of its Interpretation Platform with Artificial Intelligence (AI) Powered Gene Ranker to Enable Faster and More Efficient Clinical Analysis

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Multiscore, an advanced…
Andy
Love0
EmergentRocketvaxNews
March 12, 2025

Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates

GAITHERSBURG, Md. and BASEL, Switzerland, March 12, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS), a leading public health company that delivers protective and life-saving…
Andy
Love0
CellphireNews
March 12, 2025

Rockville’s Cellphire Therapeutics CLPH-511 Fast Track Designation Granted

Rockville, Md. (March 11, 2025) – Cellphire Therapeutics, Inc., a clinical stage biotechnology company developing next-generation allogeneic, platelet-derived, cellular therapeutics,…
Andy
Love0
IONQ LogoNews
March 12, 2025

IonQ Raises Over $372 Million Via At-the-Market Equity Offering Program

COLLEGE PARK, Md.--(BUSINESS WIRE)-- IonQ, Inc. (NYSE: IONQ), a leader in the quantum computing and quantum networking industries, today announced that…
Andy
Love0
View All Posts